Pietschmann Lab

A major step for HCV research

Research team from Hannover adapts hepatitis C virus to infect mouse liver cells

New research group “Computational Virology” at TWINCORE

Group leader Chris Lauber funded by RESIST 

Searching for drugs against SARS-CoV-2

RESIST-Scientist Professor Pietschmann, head of the TWINCORE Insitute for Experimental Virology, leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in the world's largest substance repurposing bank "ReFrame".

25 September 2013 HAI at TWINCORE

20. August 2013 Becton-Dickinson Biosciences PhD prize for Kathrin Hüging

5 July 2013 Specific characteristics of hepatitis C virus - a first step towards individualized HCV therapy

Thomas Pietschmann elected to the Executive Board of the DZIF

DZIF Press Release

Volkswagen Stiftung funds research on antiviral agents

Team led by TWINCORE virologist Pietschmann receives around 700,000 euros for RSV project 

New hope in the fight against RSV

TWINCORE researchers discover promising drug candidate 

Bacterial weapons against viral diseases

Discovery of two novel classes of natural products with activity against RNA viruses 

Lipid-lowering drugs not a risk factor in COVID-19.

Statins do not increase infectivity or viral replication of SARS-CoV-2

A precise measure of protective immunity

New tool aims to make HCV vaccine search easier

Two murine restriction factors limiting hepatitis C infection described

Research team at TWINCORE, with international collaborators, clarifies why mice are not susceptible to infection with hepatitis C virus 

Eliminating hepatitis C viruses effectively

Protein complex for hepatitis C-virus entry in liver cells is characterised

New treatment approach for hepatitis E infections in pregnant women

New perspectives for research on hepatitis C virus

WHO handrub formulations are effective against emerging viruses

Combined strength – immune cells cooperate in HIV defence

Hepatitis C virus hijacks the host's fat metabolism

Migränetabletten gegen Hepatitis C – Flunarizin hemmt den Viruseintritt in die Leberzellen

Neuer antiviraler Mechanismus gegen Hepatitis C-Viren entdeckt

Bionorica Phytoneering Award 2015 for Eike Steinmann and Anggakusuma

Snapshot of a hepatitis C virus attack - new analysis method deciphers the molecular mechanism of infection

Doctoral award of the MHH for Anggakusuma

27 October 2014 Virologists want to learn from horses: horses sucessfully fend off the non-primate hepacivirus

28 October 2013 As strong as a disinfectant: breast milk inactivates hepatitis C viruses

27 August 2013 Kitchen spice against hepatitis-C - curcumin from turmeric spice prevents hepatitis C viruses to enter liver cells

7 November 2012 Hepatitis C virus infections in the drug scene - The transmission pathways of the virus

30 July 2012 Neues Schlüsselenzym für die Virusvermehrung entdeckt

Wissenschaftler des TWINCORE stören die Infektionskette des Hepatitis-C-Virus

12 June 2012 Neuer Forschungsschwerpunkt am TWINCORE - Institut für Experimentelle Virologie erforscht RNA-Viren

23 April 2012 Ein neuer Naturstoff schützt vor Infektionen mit dem Hepatitis-C-Virus

4 November 2011 ERC Starting Grant for Thomas Pietschmann

Hepatitis C am Scheideweg: Forscher am TWINCORE suchen einen Weg zu neuen Forschungsmodellen für HCV

5 July 10 A new opportunity for hepatitis C research

Better fight against hepatitis E

Neutralising antibodies can prevent severe courses